Literature DB >> 7589843

Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans.

S M Haffner1, H Miettinen, S P Gaskill, M P Stern.   

Abstract

The relative importance of insulin resistance and abnormal insulin secretion as risk factors for the development of non-insulin-dependent diabetes mellitus (NIDDM) is still controversial. Few data are available on insulin secretion as a risk factor for the development of NIDDM, especially in subjects with normal glucose tolerance. We examined the relation of fasting insulin (as a marker of insulin resistance) and the ratio of change in insulin to change in glucose during the first 30 min after glucose ingestion (delta I30/delta G30) (as a marker of insulin secretion) as predictors of the 7-year development of NIDDM in 714 initially nondiabetic Mexican-Americans. NIDDM developed in 99 subjects. The relative risk of NIDDM increased with higher quartiles of fasting insulin (quartile 1 [low], 1.0; quartile 2, 1.5; quartile 3, 2.0; and quartile 4 [high], 3.7; P < 0.0001) and lower delta I30/delta G30 (quartile 1 [low], 6.9; quartile 2, 1.9; quartile 3, 1.1; quartile 4 [high], 1.0; P < 0.001). Subjects with both increased fasting insulin and decreased delta I30/delta G30 had independent increases in NIDDM incidence (P < 0.001). Further, when we stratified subjects by baseline glucose tolerance, both increased fasting insulin and decreased delta I30/delta G30 significantly predicted NIDDM in subjects with both impaired and normal glucose tolerance at baseline. We conclude that both decreased insulin secretion (as assessed by low delta I30/delta G30) and increased insulin resistance (as assessed by fasting insulin) predict the development of NIDDM in Mexican-Americans, a group previously characterized as having hyperinsulinemia and insulin resistance.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589843     DOI: 10.2337/diab.44.12.1386

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  66 in total

Review 1.  Insights into insulin resistance and type 2 diabetes from knockout mouse models.

Authors:  T Kadowaki
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Potential of glucose-lowering drugs to reduce cardiovascular events.

Authors:  Stuart W Zarich
Journal:  Curr Diab Rep       Date:  2009-02       Impact factor: 4.810

Review 3.  Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?

Authors:  J C Florez
Journal:  Diabetologia       Date:  2008-05-27       Impact factor: 10.122

4.  A genome scan for loci linked to quantitative insulin traits in persons without diabetes: the Framingham Offspring Study.

Authors:  C I M Panhuysen; L A Cupples; P W F Wilson; A G Herbert; R H Myers; J B Meigs
Journal:  Diabetologia       Date:  2003-03-21       Impact factor: 10.122

5.  Serum phospholipid and cholesteryl ester fatty acids and estimated desaturase activities are related to overweight and cardiovascular risk factors in adolescents.

Authors:  L M Steffen; B Vessby; D R Jacobs; J Steinberger; A Moran; C-P Hong; A R Sinaiko
Journal:  Int J Obes (Lond)       Date:  2008-06-17       Impact factor: 5.095

6.  Loss of beta cell function as fasting glucose increases in the non-diabetic range.

Authors:  I F Godsland; J A R Jeffs; D G Johnston
Journal:  Diabetologia       Date:  2004-07-13       Impact factor: 10.122

7.  Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes.

Authors:  G W Mills; P J Avery; M I McCarthy; A T Hattersley; J C Levy; G A Hitman; M Sampson; M Walker
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

8.  Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study.

Authors:  A Gastaldelli; E Ferrannini; Y Miyazaki; M Matsuda; R A DeFronzo
Journal:  Diabetologia       Date:  2003-12-10       Impact factor: 10.122

9.  Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care.

Authors:  Myrlene A Staten; Michael P Stern; W Greg Miller; Michael W Steffes; Scott E Campbell
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

Review 10.  Plasma glucose concentration and prediction of future risk of type 2 diabetes.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.